Colin P. Dinney

ORCID: 0000-0002-8969-711X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Epigenetics and DNA Methylation
  • Urological Disorders and Treatments
  • Cancer Immunotherapy and Biomarkers
  • Cancer Research and Treatments
  • Renal cell carcinoma treatment
  • Peptidase Inhibition and Analysis
  • Cancer, Hypoxia, and Metabolism
  • Ferroptosis and cancer prognosis
  • Esophageal Cancer Research and Treatment
  • Multiple and Secondary Primary Cancers
  • Cancer, Lipids, and Metabolism
  • Infectious Disease Case Reports and Treatments
  • Angiogenesis and VEGF in Cancer
  • Advanced Breast Cancer Therapies
  • Adenosine and Purinergic Signaling
  • Cancer-related molecular mechanisms research
  • Tissue Engineering and Regenerative Medicine
  • Virus-based gene therapy research
  • Prostate Cancer Diagnosis and Treatment
  • Urinary Bladder and Prostate Research
  • Metastasis and carcinoma case studies
  • Renal and related cancers
  • Prostate Cancer Treatment and Research

The University of Texas MD Anderson Cancer Center
2016-2025

Scripps MD Anderson Cancer Center
2024

Columbia University Irving Medical Center
2019-2023

Oxfam
2023

Liechtenstein Institute
2023

John Wiley & Sons (United States)
2023

Urological Society of Australia and New Zealand
2023

University of Houston
2020

University of Minnesota Rochester
2020

The University of Texas Health Science Center at Houston
2009-2019

Nathaniel Rothman Montserrat García‐Closas Nilanjan Chatterjee Núria Malats Xifeng Wu and 95 more Jonine D. Figueroa Francisco X. Real David Van Den Berg Giuseppe Matullo Dalsu Baris Michael J. Thun Lambertus A. Kiemeney Paolo Vineis Immaculata De Vivo Demetrius Albanes Mark P. Purdue Þórunn Rafnar Michelle A.T. Hildebrandt Anne E. Kiltie Olivier Cussenot Klaus Golka Rajiv Kumar Jack A. Taylor José Mayordomo Kevin B. Jacobs Manolis Kogevinas Amy Hutchinson Zhaoming Wang Yi‐Ping Fu Ludmila Prokunina‐Olsson Laurie Burdett Meredith Yeager William Wheeler Adonina Tardón Consol Serra Alfredo Carrato Reina García-Closas Josep Lloreta Alison Johnson Molly Schwenn Margaret R. Karagas Alan R. Schned Gerald L. Andriole Robert L. Grubb Amanda Black Eric J. Jacobs W. Ryan Diver Susan M. Gapstur Stephanie J. Weinstein Jarmo Virtamo Victoria K. Cortessis Manuela Gago‐Dominguez Malcolm C. Pike Mariana C. Stern Jian‐Min Yuan David J. Hunter Monica McGrath Colin P. Dinney Bogdan Czerniak Meng Chen Hushan Yang Sita H. Vermeulen Katja K.H. Aben J.A. Witjes Remco R. Makkinje Patrick Sulem Søren Besenbacher Kári Stéfansson Elio Ríboli Paul Brennan Salvatore Panico Carmen Navarro Naomi E. Allen H. Bas Bueno-de-Mesquita Dimitrios Trichopoulos Neil E. Caporaso Maria Teresa Landi Federico Canzian Börje Ljungberg Anne Tjønneland Françoise Clavel‐Chapelon D. Timothy Bishop Mark Teo Margaret A. Knowles Simonetta Guarrera Silvia Polidoro Fulvio Ricceri Carlotta Sacerdote Alessandra Allione Géraldine Cancel‐Tassin Silvia Selinski Jan G. Hengstler H. Dietrich Tony Fletcher Péter Rudnai Eugen Gurzău Kvetoslava Koppová Sophia C.E. Bolick Ashley C. Godfrey Zongli Xu

10.1038/ng.687 article EN Nature Genetics 2010-10-24

The epithelial-to-mesenchymal transition (EMT) is a cell development-regulated process in which noncoding RNAs act as crucial modulators. Recent studies have implied that EMT may contribute to resistance epidermal growth factor receptor (EGFR)-directed therapy. aims of this study were determine the potential role microRNAs (miRNA) controlling and inducing sensitivity human bladder cancer cells inhibitory effects anti-EGFR therapy.miRNA array screening real-time reverse transcription-PCR used...

10.1158/1078-0432.ccr-08-2245 article EN Clinical Cancer Research 2009-08-12

To evaluate ability of the University California Los Angeles Integrated Staging System (UISS) to stratify patients with localized and metastatic renal cell carcinoma (RCC) into risk groups in an international multicenter study.4,202 from eight academic centers were classified according UISS, which combines TNM stage, Fuhrman grade, Eastern Cooperative Oncology Group performance status. Distribution UISS categories was assessed overall population each center.The stratified both RCC three...

10.1200/jco.2004.09.104 article EN Journal of Clinical Oncology 2004-08-14

Open AccessJournal of UrologyAdult Urology5 May 2024Efficacy Intravesical Nadofaragene Firadenovec for Patients with BCG-Unresponsive Non–muscle Invasive Bladder Cancer: 5 Year Follow-Up from a Phase 3 Trial Vikram M. Narayan, Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, Joseph E. Busby, Michael Poch, Paul L. Crispen, Gary Steinberg, Anne K. Schuckman, Tracy Downs,...

10.1097/ju.0000000000004020 article EN cc-by-nc-nd The Journal of Urology 2024-05-05

No AccessJournal of UrologyClinical Urology: Original Articles1 Apr 1998STAGE SPECIFIC GUIDELINES FOR SURVEILLANCE AFTER RADICAL NEPHRECTOMY LOCAL RENAL CELL CARCINOMA DAVID A. LEVY, JOEL W. SLATON, SWANSON, and COLIN P.N. DINNEY LEVYDAVID LEVY , SLATONJOEL SLATON SWANSONDAVID SWANSON DINNEYCOLIN View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)63541-9AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail...

10.1016/s0022-5347(01)63541-9 article EN The Journal of Urology 1998-04-01

Understanding the mechanism of prostate cancer metastasis is essential to design a more effective therapy. An therapy for this disease will depend on development clinically relevant in vivo model.We describe such model by using orthotopic implantation human cells BALB/c nude mice.We compared tumorigenicity and incidence PC-3M LNCaP-FGC (LNCaP) cell lines subsequent prostatic (orthotopic) or subcutaneous (ectopic) implantations male mice.LNCaP produced tumors only prostate. Enhanced at site...

10.1093/jnci/84.12.951 article EN JNCI Journal of the National Cancer Institute 1992-06-17

Abstract MicroRNAs (miRNA) are small noncoding RNA molecules involved in a diversity of cellular functions. Although it has been reported that global suppression the miRNA biogenesis pathway leads to enhanced tumorigenesis, effect common genetic variants miRNA-related genes on cancer predisposition is unclear. To better understand this effect, we genotyped 41 single-nucleotide polymorphisms (SNP) from 24 case-control study conducted 746 Caucasian patients with bladder and matched controls....

10.1158/0008-5472.can-07-5991 article EN Cancer Research 2008-04-01
Coming Soon ...